Concepedia

Marivic Narciso-Abraham

MN

Statistics

Publications

2

Citations

221

H-Index

2

Active since

2023

Affiliations

Valneva (Austria)(Current)

Marivic Narciso-Abraham is an author at Valneva (Austria) specializing in vaccine development, vaccine safety, and vaccination.

Top concepts

Publications per year

2023–2024

2

Publications

2

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl et al. · The Lancet · 2023 · 192 citations · Full text

Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study

Robert P. McMahon, Sebastian Toepfer, Natascha Sattler et al. · The Lancet Infectious Diseases · 2024 · 29 citations

, , +7

1–2 of 2